SUBSCRIBE
SUBSCRIBE
News   Policy

US FDA Objects to Dendreon Corporation Promotions for Provenge

August 9, 2010 | 
1 min read
Reuters -- Dendreon Corp exaggerated the benefits of its novel prostate cancer vaccine and downplayed risks in some sales materials for the product, U.S. regulators said in a letter released on Friday.
Legal Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
CDC
Republicans Ratchet Up Pressure as Monarez Levels Damning Allegations Against Kennedy
September 17, 2025
 · 
4 min read
 · 
Heather McKenzie
Businessman tied up with red tape. concept of struggle, limitation and trap or challenge
FDA
FDA’s Ad Crackdown Targets Novo, Lilly’s Oprah Special on GLP-1s
September 17, 2025
 · 
3 min read
 · 
Annalee Armstrong
Podcast
China Crackdown, UK Exit, Novo Layoffs, Adcomm Flip Flop, More
September 17, 2025
 · 
2 min read
 · 
Heather McKenzie
man pulling each of the opposite ends of a rope in black and white, on a blue background with some blank space on top
Obesity
Novo, Lilly Jostle For Market Lead in Obesity With New Regulatory Efforts
September 16, 2025
 · 
2 min read
 · 
Tristan Manalac